microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1

Pengfei Lei1, Jie Xie1, Long Wang1

  • 1Department of Orthopedics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.

Insights

MicroRNA-145 (miR-145) suppresses osteosarcoma (OS) growth and spread by targeting ROCK1. This discovery offers potential new diagnostic and therapeutic strategies for this bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents.
  • Reduced levels of microRNA-145 (miR-145) are linked to OS aggressiveness and metastasis.
  • The precise mechanism of miR-145's tumor-suppressive role in OS is not fully understood.

Purpose of the Study:

  • To elucidate the regulatory mechanism of miR-145 in osteosarcoma.
  • To identify novel molecular targets of miR-145 in OS.
  • To investigate the potential of miR-145 as a diagnostic and therapeutic agent for OS.

Main Methods:

  • Quantified miR-145 and Rho-associated protein kinase 1 (ROCK1) expression in OS tissues and cell lines.
  • Utilized cell culture models (KHOS, U2OS) to study miR-145 and ROCK1 interactions.
  • Performed gain-of-function experiments for miR-145 and rescue experiments with ROCK1 restoration.

Main Results:

  • miR-145 was significantly downregulated in OS tissues and cell lines.
  • ROCK1 was identified as a direct target of miR-145, with miR-145 suppressing ROCK1 protein but not mRNA levels.
  • ROCK1 expression was elevated in OS tissues and cells.
  • Overexpression of miR-145 inhibited OS cell proliferation and invasion, effects that were reversed by restoring ROCK1.

Conclusions:

  • miR-145 functions as a tumor suppressor in osteosarcoma.
  • miR-145 inhibits OS cell proliferation and invasion, partly through direct targeting of ROCK1.
  • miR-145 represents a potential biomarker and therapeutic target for osteosarcoma.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K